Abstract:Background Vascular calcification (VC), associated with enhanced cardiovascular morbidity and mortality, is characterized by the osteogenic transdifferentiation of vascular smooth muscle cells. Inflammation promotes VC initiation and progression. Interleukin (IL)‐29, a newly discovered member of type III interferon, has recently been implicated in the pathogenesis of autoimmune diseases. Here we evaluated the role of IL‐29 in the VC process and underlying inflammatory mechanisms. Methods and Results The mRNA expression of IL‐29 was significantly increased and positively associated with an increase in BMP2 (bone morphogenetic protein 2) mRNA level in calcified carotid arteries from patients with coronary artery disease or chronic kidney disease. IL‐29 and BMP2 proteins are colocalized in human calcified arteries. IL‐29 binding to its specific receptor IL‐28Rα (IL‐28 receptor α) (IL‐29/IL‐28Rα) inhibited the proliferation of rat vascular smooth muscle cells without altering cell apoptosis or migration. IL‐29 promoted the calcification of rat vascular smooth muscle cells and their osteogenic transdifferentiation in vitro as well as the rat aortic ring calcification ex vivo, induced by the calcification medium or osteogenic medium. The procalcification effect of IL‐29 was reduced by pharmacological inhibition of IL‐29/IL‐28Rα binding as well as suppression of janus kinase 2/signal transducer and activator of transcription pathway activation, accompanied by decreased BMP2 expression in the cultured rat vascular smooth muscle cells. Conclusions These results suggest an important role of IL‐29 in VC development, at least partly, via activating the janus kinase 2/signal transducer and activator of transcription 3 signaling. Inhibition of IL‐29 or its specific receptor, IL‐28Rα, may provide a novel strategy to reduce VC in patients with vascular diseases. Nonstandard Abbreviations and Acronyms ARS alizarin red S BMP2 bone morphogenetic protein 2 VC vascular calcification VSMC vascular smooth muscle cell Clinical Perspective What Is New? Interleukin (IL)‐29 expression is increased in calcified carotid arteries from patients with coronary artery disease or chronic kidney disease, positively associated with BMP2 (bone morphogenetic protein 2) mRNA, and colocalizes with BMP2 protein. IL‐29, as a proinflammatory cytokine, binds to its specific receptor, IL‐28Rα (interleukin receptor α), on vascular smooth muscle cells, at least partly activating janus kinase 2/signal transducer and activator of transcription 3 signaling pathway to upregulate BMP2 expression in vascular smooth muscle cells, and promotes their osteogenic transformation and calcification. What Are the Clinical Implications? Our results indicate that inhibition of IL‐29/IL‐28Rα and/or janus kinase 2/signal transducer and activator of transcription 3 signaling using synthetic, small molecule inhibitors may be a useful strategy to reduce vascular calcification–related diseases. Vascular calcification (VC) is characterized by the deposition of calcium phosphate complexes in the arterial wall, and categorized by the intimal and medial calcification, depending on the sites of mineral deposition within the affected vessels. 1 Although it is regarded as a part of the normal aging process, VC has been implicated in the vascular pathogenesis associated with diabetes, 2 atherosclerosis, 3 and chronic kidney disease (CKD). 4 , 5 VC is considered as a hallmark of atherosclerosis and a key prognostic indicator of CKD that highly correlates with increased cardiovascular morbidity and mortality. 6 Although originally thought to be a passive, inevitable, and unregulated pathology process, VC is now appreciated to be an active and cell‐mediated process, 7 principally driven by vascular smooth muscle cells (VSMCs) 8 and tightly regulated by an array of inducers and inhibitors. 9 , 10 There is accumulating evidence suggesting that VSMC calcification plays a central role in the development and progression of VC. Importantly, phenotype sw -Abstract Truncated-

High Phosphate-Induced JAK-STAT Signalling Sustains Vascular Smooth Muscle Cell Inflammation and Limits Calcification

Interleukin‐29 Accelerates Vascular Calcification via JAK2/STAT3/BMP2 Signaling

MO759: Indoxyl-Sulfate Activation of the AhR-NFΚB Pathway Promotes IL-6 Secretion and Subsequent Osteogenic Transition and Calcification of Interstitial Cells of the Aortic Valve

LPS-induced senescence of macrophages aggravates calcification and senescence of vascular smooth muscle cells via IFITM3

Targeting Androgen Receptor in Macrophages Inhibits Phosphate-Induced Vascular Smooth Muscle Cell Calcification by Decreasing IL-6 Expression

Hypoxia-Inducible Factor-1α Regulates High Phosphate-Induced Vascular Calcification via Type III Sodium-Dependent Phosphate Cotransporter 1

Hypoxia-inducible factor activation promotes osteogenic transition of valve interstitial cells and accelerates aortic valve calcification in a mice model of chronic kidney disease

Activation of CD137 Signaling Enhances Vascular Calcification Through C-Jun N-Terminal Kinase-Dependent Disruption of Autophagic Flux

Wnt signaling contributes to vascular calcification by induction of matrix metalloproteinases

Aortic valve calcification is promoted by interleukin-8 and restricted through antagonizing CXC motif chemokine receptor 2

Indoxyl Sulfate-induced Vascular Calcification is mediated through Altered Notch Signaling Pathway in Vascular Smooth Muscle Cells

Label-free Quantitative Proteomics Identifies Smarca4 is Involved in Vascular Calcification

Indoxyl sulfate-induced calcification of vascular smooth muscle cells via the PI3K/Akt/NF-κB signaling pathway.

Exosomal STAT1 derived from high phosphorus-stimulated vascular endothelial cells induces vascular smooth muscle cell calcification via the Wnt/-catenin signaling pathway

Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in CKD

The microRNA-34a-Induced Senescence-Associated Secretory Phenotype (SASP) Favors Vascular Smooth Muscle Cells Calcification

The novel role of complement 3 in Wnt5a-mediated vascular smooth muscle cell calcification

Indoxyl Sulfate-Induced Valve Endothelial Cell Endothelial-to-Mesenchymal Transition and Calcification in an Integrin-linked Kinase-Dependent Manner

C5a-C5aR1 induces endoplasmic reticulum stress to accelerate vascular calcification via PERK-eIF2α-ATF4-CREB3L1 pathway

Aortic valve calcification is promoted by interleukin-8 and restricted through antagonizing CXCR2.

Indoxyl Sulfate Promotes Osteogenic Differentiation of Vascular Smooth Muscle Cells by Mir-155-5p-dependent Downregulation of Matrix Gla Protein Via ROS/NF-κB Signaling